Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHowden Joinery Regulatory News (HWDN)

Share Price Information for Howden Joinery (HWDN)

Share Price is delayed by 15 minutes
Get Live Data
779.00    24.00 (3.18%)
Bid:
782.00
Ask:
782.50
Spread: 0.50 (0.064%)
Market Cap: £4.21b
HWDN Live PriceLast checked at - London Stock Exchange

Intraday Howden Joinery Share Chart

Share Buyback Programme

29 Jul 2025 07:00

RNS Number : 8608S
Howden Joinery Group PLC
29 July 2025
 

29 July 2025

 

HOWDEN JOINERY GROUP PLC

("Howdens" or the "Company")

 

SHARE BUYBACK PROGRAMME

 

Further to (i) the announcement of Howdens' intention to repurchase up to £100 million of its shares over the next 12 months in its 2024 Full Year Results (the "Programme"); and (ii) the announcement on 13 March 2025 of the first £50 million tranche of the Programme to be executed by Deutsche Numis, the Company announces that it has entered into an arrangement with Barclays Bank PLC, acting through its investment bank ("Barclays") in respect of the second £50 million tranche of the Programme. The arrangement allows Barclays to purchase, together with any other ordinary shares in the Company (the "Shares") purchased on the Company's behalf pursuant to its buyback programme, up to (a) prior to the expiration of the Company's current buyback authority granted by shareholder resolution dated 1 May 2025, 54,974,739 Shares; and (b) following such expiration, the aggregate number of Shares authorised to be purchased by the Company under any subsequent buyback authority granted during the arrangement (which in any event shall be less than 15% of the relevant class of the Company's equity shares at the date of such authority) during the period from the date of this announcement and no later than 25 February 2026. These share purchases will be made by Barclays acting as riskless principal and in accordance with the arrangement and, in the case of any purchases made during closed periods, shall be made independently of and uninfluenced by the Company.

 

Any share purchases effected pursuant to the arrangement will be subject to the terms of the arrangement with Barclays and in any case will be effected in a manner consistent with both the general authority vested in the Company to repurchase shares and the Financial Conduct Authority's Listing Rules. The aggregate purchase price under this arrangement, together with any other Shares purchased on the Company's behalf pursuant to its buyback programme, will not exceed £100,000,000.

 

Following the purchase of the Shares, they will either be cancelled or placed into treasury for the sole purpose of meeting future obligations arising from Company employee share option programmes.

 

Further information on the Company can be found on our website: www.howdenjoinerygroupplc.com

 

Enquiries

 

Mark Fearon, Director of IR and Communications:

+44(0)771 187 5070

Forbes McNaughton, Company Secretary:

+44(0)207 535 1162

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWUVRVWUBUAR
Date   Source Headline
10th Jul 20241:04 pmRNSHolding(s) in Company
9th Jul 20243:06 pmRNSHolding(s) in Company
3rd Jul 20242:31 pmRNSHolding(s) in Company
1st Jul 20242:23 pmRNSHolding(s) in Company
1st Jul 202412:00 pmRNSTotal Voting Rights
1st Jul 202411:59 amRNSTotal Voting Rights – Replacement
1st Jul 202411:58 amRNSTransfer of Treasury Shares
20th Jun 20241:57 pmRNSHolding(s) in Company
20th Jun 202410:24 amRNSSIP PDMR Notification
17th Jun 20243:00 pmRNSDirector/PDMR Shareholding
11th Jun 20242:01 pmRNSHolding(s) in Company
3rd Jun 20249:00 amRNSTotal Voting Rights
31st May 20245:26 pmRNSHolding(s) in Company
31st May 20249:00 amRNSHolding(s) in Company
29th May 20242:47 pmRNSHolding(s) in Company
29th May 202410:12 amRNSDirector/PDMR Shareholding
28th May 20249:35 amRNSHolding(s) in Company
23rd May 20244:58 pmRNSHolding(s) in Company
23rd May 20249:30 amRNSDirector/PDMR Shareholding
20th May 202410:43 amRNSSIP PDMR Notification
7th May 20242:00 pmRNSDirectorate Change
2nd May 20242:25 pmRNSResult of AGM
2nd May 20249:36 amRNSDirector/PDMR Shareholding
2nd May 20249:00 amRNSAGM Statement
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSTrading Update
22nd Apr 20241:29 pmRNSHolding(s) in Company
19th Apr 20244:10 pmRNSSIP PDMR Notification
15th Apr 20244:32 pmRNSHolding(s) in Company
10th Apr 20245:25 pmRNSHolding(s) in Company
10th Apr 20242:30 pmRNSDirector/PDMR Shareholding
10th Apr 20249:35 amRNSTransfer of Treasury Shares
2nd Apr 20249:00 amRNSTotal Voting Rights
26th Mar 202412:51 pmRNSDirector/PDMR Shareholding
20th Mar 20244:06 pmRNSSIP PDMR Notification
20th Mar 20249:02 amRNSAnnual Report and Accounts and Notice of AGM
20th Mar 20249:00 amRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20245:04 pmRNSHolding(s) in Company
12th Mar 20242:27 pmRNSHolding(s) in Company
12th Mar 20242:09 pmRNSHolding(s) in Company
1st Mar 202411:30 amRNSTotal Voting Rights
29th Feb 20247:00 amRNS2023 Full Year Results
20th Feb 20249:00 amRNSSIP PDMR Notification
1st Feb 20249:00 amRNSBlock listing Interim Review
1st Feb 20249:00 amRNSTotal Voting Rights
19th Jan 20244:17 pmRNSSIP PDMR Notification
2nd Jan 20249:00 amRNSTotal Voting Rights
19th Dec 20233:49 pmRNSSIP PDMR Notification
8th Dec 20235:59 pmRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.